Publications by authors named "Thomas Hultsch"


Recognizing that the microbiome is part of the human immune system will advance treatment of both cancer and infections.

J Am Acad Dermatol 2016 Apr;74(4):772-4

Department of Pediatrics, University of California, San Diego, La Jolla, California.

View Article and Find Full Text PDF
April 2016

Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trial.

Dermatology 2010 Aug 8;221(1):71-7. Epub 2010 Jun 8.

University of Minnesota School of Medicine, Department of Dermatology, Minneapolis, MN 55455, USA.

View Article and Find Full Text PDF
August 2010

Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study.

J Dtsch Dermatol Ges 2010 Dec;8(12):990-8

Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Austria.

View Article and Find Full Text PDF
December 2010

Pimecrolimus enhances TLR2/6-induced expression of antimicrobial peptides in keratinocytes.

J Invest Dermatol 2008 Nov 22;128(11):2646-2654. Epub 2008 May 22.

Division of Dermatology, Department of Medicine, University of California, San Diego and VA San Diego Healthcare System, San Diego, California, USA. Electronic address:

View Article and Find Full Text PDF
November 2008

Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.

Dermatology 2005 ;211(2):174-87

Novartis Pharmaceuticals Corporation, East Hanover, NJ 0793-1080, USA.

View Article and Find Full Text PDF
December 2005

Current management of atopic dermatitis and interruption of the atopic march.

J Allergy Clin Immunol 2003 Dec;112(6 Suppl):S140-50

Division of Pediatric Allergy-Immunology, National Jewish Medical Research Center and University of Colorado School of Medicine, Denver, Colorado 80206, USA.

View Article and Find Full Text PDF
December 2003